SLC16A1 and neoplasm: In 2017, Chen et al. reported a MCT1-independent perillyl alcohol-conjugated analog of 3-BrPA, which induced obvious cytotoxicity in highly 3-BrPA-resistant tumor cells with negative MCT1 [66].